Twist Bioscience Corporation Interest Expense
Twist Bioscience Corporation (TWST) reported Interest Expense of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-02
- Twist Bioscience Corporation interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Twist Bioscience Corporation interest expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Twist Bioscience Corporation interest expense for the quarter ending 2023-09-30 was $1.00K, a 96.15% decline year-over-year.
- Twist Bioscience Corporation interest expense for the quarter ending 2023-06-30 was $1.00K.
- Twist Bioscience Corporation interest expense for fiscal 2023 was $5.00K, a 93.75% decline from fiscal 2022.
- Twist Bioscience Corporation interest expense for fiscal 2022 was $80.00K, a 78.20% decline from fiscal 2021.
- Twist Bioscience Corporation interest expense for fiscal 2021 was $367.00K, a 53.37% decline from fiscal 2020.
- Twist Bioscience Corporation interest expense for fiscal 2020 was $787.00K, a 39.18% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 10-Q · filed 2024-05-02 | $1.00K derived: sum of 3 quarters · filed 2024-05-02 | $2.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-02 | $1.00K derived: sum of 2 quarters · filed 2024-02-02 | $2.00K derived: sum of 3 quarters · filed 2024-02-02 | $4.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-09-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $2.00K derived: sum of 2 quarters · filed 2023-11-21 | $4.00K derived: sum of 3 quarters · filed 2024-05-02 | $5.00K 10-K · filed 2023-11-21 |
| 2023-06-30 | $1.00K 10-Q · filed 2023-08-07 | $3.00K derived: sum of 2 quarters · filed 2024-05-02 | $4.00K 10-Q · filed 2023-08-07 | $30.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-02 | $3.00K 10-Q · filed 2024-05-02 | $29.00K derived: sum of 3 quarters · filed 2024-05-02 | $29.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $1.00K 10-Q · filed 2024-02-02 | $27.00K derived: sum of 2 quarters · filed 2024-02-02 | $27.00K derived: sum of 3 quarters · filed 2024-02-02 | $56.00K derived: sum of 4 quarters · filed 2024-02-02 |
| 2022-09-30 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $26.00K derived: sum of 2 quarters · filed 2023-11-21 | $55.00K derived: sum of 3 quarters · filed 2023-11-21 | $80.00K 10-K · filed 2023-11-21 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $29.00K derived: sum of 2 quarters · filed 2023-08-07 | $54.00K 10-Q · filed 2023-08-07 | $138.00K derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | $29.00K 10-Q · filed 2023-05-08 | $54.00K 10-Q · filed 2023-05-08 | $138.00K derived: sum of 3 quarters · filed 2023-11-21 | $208.00K derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | $26.00K 10-Q · filed 2023-02-07 | $109.00K derived: sum of 2 quarters · filed 2023-11-21 | $179.00K derived: sum of 3 quarters · filed 2023-11-21 | $274.00K derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $153.00K derived: sum of 2 quarters · filed 2023-11-21 | $248.00K derived: sum of 3 quarters · filed 2023-11-21 | $367.00K 10-K · filed 2023-11-21 |
| 2021-06-30 | $70.00K 10-Q · filed 2022-08-08 | $165.00K derived: sum of 2 quarters · filed 2022-08-08 | $284.00K 10-Q · filed 2022-08-08 | $426.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2021-03-31 | $95.00K 10-Q · filed 2022-05-06 | $213.00K 10-Q · filed 2022-05-06 | $356.00K derived: sum of 3 quarters · filed 2023-06-05 | $537.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2020-12-31 | $118.00K 10-Q · filed 2022-02-09 | $261.00K derived: sum of 2 quarters · filed 2023-06-05 | $442.00K derived: sum of 3 quarters · filed 2023-06-05 | $657.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2020-09-30 | $143.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-05 | $324.00K derived: sum of 2 quarters · filed 2023-06-05 | $539.00K derived: sum of 3 quarters · filed 2023-06-05 | $787.00K 10-K/A · filed 2023-06-05 |
| 2020-06-30 | $181.00K 10-Q · filed 2021-08-09 | $396.00K derived: sum of 2 quarters · filed 2021-08-09 | $644.00K 10-Q · filed 2021-08-09 | $931.00K derived: sum of 4 quarters · filed 2021-11-23 |
| 2020-03-31 | $215.00K 10-Q · filed 2021-05-07 | $463.00K 10-Q · filed 2021-05-07 | $750.00K derived: sum of 3 quarters · filed 2021-11-23 | $1.07M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-12-31 | $248.00K 10-Q · filed 2021-02-09 | $535.00K derived: sum of 2 quarters · filed 2021-11-23 | $853.00K derived: sum of 3 quarters · filed 2021-11-23 | $1.19M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-09-30 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $605.00K derived: sum of 2 quarters · filed 2021-11-23 | $945.00K derived: sum of 3 quarters · filed 2021-11-23 | $1.29M 10-K · filed 2021-11-23 |
| 2019-06-30 | $318.00K 10-Q · filed 2020-08-12 | $658.00K derived: sum of 2 quarters · filed 2020-08-12 | $1.01M 10-Q · filed 2020-08-12 | $1.39M derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-03-31 | $340.00K 10-Q · filed 2020-05-13 | $688.00K 10-Q · filed 2020-05-13 | $1.07M derived: sum of 3 quarters · filed 2020-11-27 | $1.41M derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-12-31 | $348.00K 10-Q · filed 2020-02-10 | $734.00K derived: sum of 2 quarters · filed 2020-11-27 | $1.07M derived: sum of 3 quarters · filed 2020-11-27 | $1.39M derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-09-30 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-27 | $723.00K derived: sum of 2 quarters · filed 2020-11-27 | $1.04M derived: sum of 3 quarters · filed 2020-11-27 | $1.31M 10-K · filed 2020-11-27 |
| 2018-06-30 | $337.00K 10-Q · filed 2019-08-09 | $654.00K derived: sum of 2 quarters · filed 2019-08-09 | $927.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $317.00K 10-Q · filed 2019-05-02 | $590.00K 10-Q · filed 2019-05-02 | ||
| 2017-12-31 | $273.00K 10-Q · filed 2019-02-11 | |||
| 2017-09-30 | $905.00K 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |